SODIUM BICARBONATE

Sodium Bicarbonate Adverse Events Reported to the FDA Over Time

How are Sodium Bicarbonate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sodium Bicarbonate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sodium Bicarbonate is flagged as the suspect drug causing the adverse event.

Most Common Sodium Bicarbonate Adverse Events Reported to the FDA

What are the most common Sodium Bicarbonate adverse events reported to the FDA?

Off Label Use	26 (2.02%)
Toxic Epidermal Necrolysis	23 (1.78%)
Medication Error	22 (1.71%)
Drug Toxicity	19 (1.47%)
Loss Of Consciousness	16 (1.24%)
Dyspnoea	15 (1.16%)
Injection Site Pain	15 (1.16%)
Blood Pressure Decreased	14 (1.09%)
Nausea	14 (1.09%)
Vomiting	14 (1.09%)
Completed Suicide	12 (.93%)
	Show More
Cardiac Arrest	11 (.85%)
Injection Site Erythema	11 (.85%)
Pyrexia	11 (.85%)
Erythema	10 (.78%)
Hypokalaemia	10 (.78%)
Renal Failure	10 (.78%)
Drug Exposure During Pregnancy	9 (.7%)
Drug Ineffective	9 (.7%)
Metabolic Acidosis	9 (.7%)
Oedema Peripheral	9 (.7%)
Pain	9 (.7%)
Pneumonia	9 (.7%)
Product Quality Issue	9 (.7%)
Rhabdomyolysis	9 (.7%)
Asthenia	8 (.62%)
Death	8 (.62%)
Hypersensitivity	8 (.62%)
Respiratory Failure	8 (.62%)
Abdominal Pain Upper	7 (.54%)
Apparent Death	7 (.54%)
Blister	7 (.54%)
Dizziness	7 (.54%)
Granuloma	7 (.54%)
Injection Site Oedema	7 (.54%)
Respiratory Arrest	7 (.54%)
Sneezing	7 (.54%)
Stevens-johnson Syndrome	7 (.54%)
Acidosis Hyperchloraemic	6 (.47%)
Blood Creatinine Increased	6 (.47%)
Blood Pressure Increased	6 (.47%)
Chills	6 (.47%)
Condition Aggravated	6 (.47%)
Contusion	6 (.47%)
Diarrhoea	6 (.47%)
Drug Dependence	6 (.47%)
Fall	6 (.47%)
Feeling Abnormal	6 (.47%)
Hypotension	6 (.47%)
Injection Site Swelling	6 (.47%)
Necrosis	6 (.47%)
Pruritus	6 (.47%)
Wrong Technique In Drug Usage Proce...	6 (.47%)
Abortion Spontaneous	5 (.39%)
Acute Generalised Exanthematous Pus...	5 (.39%)
Cardio-respiratory Arrest	5 (.39%)
Decreased Appetite	5 (.39%)
Extravasation	5 (.39%)
Haemodialysis	5 (.39%)
Hallucination, Auditory	5 (.39%)
Headache	5 (.39%)
Hyperhidrosis	5 (.39%)
Injection Site Rash	5 (.39%)
Joint Swelling	5 (.39%)
Laceration	5 (.39%)
Memory Impairment	5 (.39%)
Overdose	5 (.39%)
Rash	5 (.39%)
Ventricular Tachycardia	5 (.39%)
Visual Acuity Reduced	5 (.39%)
Abdominal Pain	4 (.31%)
Cardiac Disorder	4 (.31%)
Chest Pain	4 (.31%)
Circumstance Or Information Capable...	4 (.31%)
Convulsion	4 (.31%)
Cough	4 (.31%)
Depression	4 (.31%)
Drug Interaction	4 (.31%)
Ecchymosis	4 (.31%)
Fatigue	4 (.31%)
Haemorrhage Subcutaneous	4 (.31%)
Hypernatraemia	4 (.31%)
Hyperuricaemia	4 (.31%)
Hypocalcaemia	4 (.31%)
Hypophosphataemia	4 (.31%)
Inflammation	4 (.31%)
Infusion Related Reaction	4 (.31%)
Injection Site Paraesthesia	4 (.31%)
Insomnia	4 (.31%)
Malaise	4 (.31%)
Mental Disorder	4 (.31%)
Metabolic Alkalosis	4 (.31%)
Myocardial Infarction	4 (.31%)
Product Substitution Issue	4 (.31%)
Pulmonary Fibrosis	4 (.31%)
Renal Failure Acute	4 (.31%)
Respiratory Distress	4 (.31%)
Scar	4 (.31%)
Skin Lesion	4 (.31%)
Unevaluable Event	4 (.31%)
Urinary Tract Infection	4 (.31%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Sodium Bicarbonate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sodium Bicarbonate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sodium Bicarbonate

What are the most common Sodium Bicarbonate adverse events reported to the FDA?

Epidermal And Dermal Conditions	84 (6.51%)
Respiratory	69 (5.35%)
Administration Site Reactions	62 (4.81%)
Medication Errors	55 (4.26%)
Gastrointestinal Signs	46 (3.57%)
Neurological	36 (2.79%)
Infections - Pathogen Unspecified	35 (2.71%)
Cardiac Arrhythmias	33 (2.56%)
Electrolyte And Fluid Balance Condi...	32 (2.48%)
Chemical Injury And Poisoning	30 (2.33%)
Cardiac And Vascular Investigations	27 (2.09%)
	Show More
Therapeutic Procedures And Supporti...	26 (2.02%)
Injuries	25 (1.94%)
Acid-base	24 (1.86%)
Renal Disorders	22 (1.71%)
Hematology Investigations	21 (1.63%)
Therapeutic And Nontherapeutic Effe...	21 (1.63%)
Bone, Calcium, Magnesium And Phosph...	16 (1.24%)
Suicidal And Self-injurious Behavio...	16 (1.24%)
Procedural And Device Related Injur...	15 (1.16%)
Body Temperature Conditions	14 (1.09%)
Allergic Conditions	13 (1.01%)
Product Quality Issues	13 (1.01%)
Psychiatric	13 (1.01%)
Water, Electrolyte And Mineral	12 (.93%)
Decreased And Nonspecific Blood Pre...	11 (.85%)
Hepatobiliary	11 (.85%)
Central Nervous System Vascular	10 (.78%)
Renal And Urinary Tract Investigati...	10 (.78%)
Heart Failures	9 (.7%)
Joint	9 (.7%)
Lower Respiratory Tract Disorders	9 (.7%)
Muscle	9 (.7%)
Seizures	9 (.7%)
Tissue	9 (.7%)
White Blood Cell	9 (.7%)
Fatal Outcomes	8 (.62%)
Gastrointestinal Motility And Defec...	8 (.62%)
Hepatic And Hepatobiliary	8 (.62%)
Skin Vascular Abnormalities	8 (.62%)
Bacterial Infectious	7 (.54%)
Bronchial Disorders	7 (.54%)
Deliria	7 (.54%)
Headaches	7 (.54%)
Metabolic, Nutritional And Blood Ga...	7 (.54%)
Musculoskeletal And Connective Tiss...	7 (.54%)
Urinary Tract Signs	7 (.54%)
Anxiety Disorders	6 (.47%)
Disturbances In Thinking	6 (.47%)
Enzyme	6 (.47%)
Gastrointestinal Ulceration And Per...	6 (.47%)
Hematological And Lymphoid Tissue T...	6 (.47%)
Mental Impairment	6 (.47%)
Abortions And Stillbirth	5 (.39%)
Appetite And General Nutritional	5 (.39%)
Cardiac Disorder Signs	5 (.39%)
Coronary Artery	5 (.39%)
Gastrointestinal Hemorrhages	5 (.39%)
Myocardial	5 (.39%)
Oral Soft Tissue Conditions	5 (.39%)
Skin Appendage Conditions	5 (.39%)
Vision	5 (.39%)
Anemias Nonhemolytic And Marrow Dep...	4 (.31%)
Anterior Eye Structural Change, Dep...	4 (.31%)
Arteriosclerosis, Stenosis, Vascula...	4 (.31%)
Coagulopathies And Bleeding Diathes...	4 (.31%)
Depressed Mood Disorders	4 (.31%)
Inner Ear And Viiith Cranial Nerve	4 (.31%)
Mycobacterial Infectious	4 (.31%)
Nephropathies	4 (.31%)
Ocular Infections, Irritations And ...	4 (.31%)
Protein And Amino Acid Metabolism	4 (.31%)
Purine And Pyrimidine Metabolism	4 (.31%)
Sleep Disorders	4 (.31%)
Vascular Hypertensive	4 (.31%)
Encephalopathies	3 (.23%)
Gastrointestinal Inflammatory Condi...	3 (.23%)
Immunology And Allergy	3 (.23%)
Maternal Complications Of Labour An...	3 (.23%)
Neuromuscular	3 (.23%)
Ocular Neuromuscular	3 (.23%)
Pleural	3 (.23%)
Pulmonary Vascular	3 (.23%)
Upper Respiratory Tract Disorders	3 (.23%)
Uterine, Pelvic And Broad Ligament	3 (.23%)
Bile Duct	2 (.16%)
Eating Disorders	2 (.16%)
Fungal Infectious	2 (.16%)
Gastrointestinal	2 (.16%)
Gastrointestinal Conditions	2 (.16%)
Glaucoma And Ocular Hypertension	2 (.16%)
Investigations, Imaging And Histopa...	2 (.16%)
Leukemias	2 (.16%)
Lifestyle Issues	2 (.16%)
Malabsorption Conditions	2 (.16%)
Menstrual Cycle And Uterine Bleedin...	2 (.16%)
Mood Disorders	2 (.16%)
Movement Disorders	2 (.16%)
Nervous System Neoplasms Benign	2 (.16%)
Ocular Structural Change, Deposit A...	2 (.16%)
Physical Examination Topics	2 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sodium Bicarbonate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sodium Bicarbonate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.